Development of Personalized Balanced Nutrition Concept Through an IT

Status Recruiting

Clinical Trial Summary

By achieving effective cooperation between the Children's Hospital Srebrnjak (CHS), the Reference center for clinical allergology in children of the ministry of health, and IN2 Ltd., part of Constellation Software Inc., it is planned to develop an IT platform for the introduction of personalized balanced nutrition in kindergartens. The collected data which include the screening of the population, anthropometrical measurements, physical activity status, and medical examination, will be used to create a Registry of Allergies. Through the implementation of research activities, it is expected to develop an IT platform for personalized balanced nutrition of preschool children, which consists of a developed information system for continuous monitoring using a website and/or a mobile application.

Clinical Trial Description

This study will involve kindergarten children (aged 1-6 years). The research takes place in six different phases: 1) development of the information system and data integration, 2) classification of target groups of kindergarten children according to nutritional status, 3) anthropometric monitoring of the development of kindergarten children, 4) establishment of an electronic register of allergies, 5) implementation of an information platform in kindergartens, and 6) assessment of the validity of platform. The research will include a minimum of 450 participants from Split, Osijek and Zagreb County. Based on the completed standardized questionnaires the target groups of kindergarten children will be classified according to their nutritional status: 1. children who have a developed food allergy 2. children at risk of developing mild, moderate or severe allergic reaction to food 3. children with an allergological indication The children with allergological indication (c) will be sent for further specialist evaluation, diagonstics and nutritionist advice at CHS. The investigators will monitor how many kindergarten children have developed food allergy, food intolerance and another allergy (eg. inhalation allergy). Children with another type of allergy will be the refference control. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05462444
Study type	Observational
Source	Children's Hospital Srebrnjak
Contact	Mirjana Turkalj
Phone	+38516391206
Email	mturkalj@bolnica-srebrnjak.com
Status	Recruiting
Phase
Start date	March 29, 2021
Completion date	December 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04058743` - Nickel Sensitivity	N/A
Not yet recruiting	`NCT05649891` - Checklists Resuscitation Emergency Department	N/A
Not yet recruiting	`NCT06065137` - Standardised Drug Provocation Testing in Perioperative Hypersensitivity	Phase 4
Active, not recruiting	`NCT05605795` - Investigation of Cross-allergies Between Cefazolin and Amoxicillin With Skin Tests and Provocation Test
Completed	`NCT04510376` - Allergy Potential of Omeza Collagen Matrix in Human Subjects Using the Skin Prick Method	N/A
Completed	`NCT05185479` - Analysis of Adverse Events in Anesthesia Using Artificial Intelligence
Recruiting	`NCT05185362` - Epidemiology of Pecan Nut Allergy
Completed	`NCT03525496` - Interest of Challenge Tests for Diagnosis of Immediate Hypersensitivity Against Iodinated Contrast Agents
Completed	`NCT03489694` - Repeatability and Reproducibility of Skin Test Endpoint Titration
Completed	`NCT03942692` - What is the Allergy Follow-up for Children After Anaphylactic Reaction? AFCAR : Allergy Follow-up for Children After Anaphylactic Reaction
Enrolling by invitation	`NCT05670756` - Preoperative Survey to Evaluate Patient Allergy
Not yet recruiting	`NCT05284253` - Is There an Allergy to Pure Metallic Gold Microparticles?	N/A
Completed	`NCT03157505` - Efficacy and Safety of Birch Pollen Immunotherapy in Local Allergic Rhinitis	Phase 3
Completed	`NCT01436617` - Assessing the Value of a Dosage of Anti-cetuximab in the Therapeutic Management of Patients With Colon Cancer or Upper Aero-digestive Tract and Candidates for Treatment With Cetuximab	Phase 2
Not yet recruiting	`NCT05532566` - Quercus Ilex and Quercus Robur Allergen Extracts Standardisation	N/A
Not yet recruiting	`NCT05533385` - Juniperus Oxycedrus and Cupressus Arizonica Allergen Extracts Standardisation.	N/A
Recruiting	`NCT06011603` - Prineo Sensitivity Dressing Study	Phase 4
Completed	`NCT04761822` - COVID19 SARS Vaccinations: Systemic Allergic Reactions to SARS-CoV-2 Vaccinations	Phase 2
Recruiting	`NCT05367531` - Assessment of Injectable Medication Platforms	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Development of Personalized Balanced Nutrition Concept Through an IT Platform

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms